Breaking News
Get 40% Off 0
🚀 AI-picked stocks soar in May. PRFT is +55%—in just 16 days! Don’t miss June’s top picks. Unlock full list
Close

Shin Nippon Biomedical Laboratories Ltd (2395)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
1,336.0 +29.0    +2.22%
02:00:29 - Closed. Currency in JPY ( Disclaimer )
  • Volume: 363,600
  • Bid/Ask: 1,336.0 / 1,340.0
  • Day's Range: 1,300.0 - 1,350.0
Type:  Equity
Market:  Japan
ISIN:  JP3379950003 
Shin Nippon Biomed Lab 1,336.0 +29.0 +2.22%

2395 Balance Sheet

 
Featured here, the Balance Sheet for Shin Nippon Biomedical Laboratories Ltd, which summarizes the company's financial position including assets, liabilities and shareholder equity for each of the latest 4 period ending dates (either quarterly or annually).
AnnualQuarterly
Advanced Balance Sheet
Period Ending: 2024
31/03
2023
31/12
2023
30/09
2023
30/06
Total Current Assets 30837.71 33442.77 29801 28788
Cash and Short Term Investments 10611.5 13002.34 12014 13901
Cash - - - -
Cash & Equivalents 10274.77 12779.32 10721 12610
Short Term Investments 336.72 223.03 1293 1291
Total Receivables, Net 5722.81 5604.34 5131 4049
Accounts Receivables - Trade, Net 5722.81 5604.34 5131 4049
Total Inventory 12373.18 11935.57 10003 8324
Prepaid Expenses - - - -
Other Current Assets, Total 2130.23 2900.51 2653 2514
Total Assets 76302.35 71371.71 68558 62615
Property/Plant/Equipment, Total - Net 26357.67 21348.54 20901 20369
Property/Plant/Equipment, Total - Gross 49614.97 - - -
Accumulated Depreciation, Total -23257.3 - - -
Goodwill, Net 1934.42 1965.58 1975 1994
Intangibles, Net 224.88 264.73 271 289
Long Term Investments 15235.71 12787.59 15609 11173
Note Receivable - Long Term - - - -
Other Long Term Assets, Total 689.14 1562.5 1 2
Other Assets, Total 10140.14 9454.77 8818 8080
Total Current Liabilities 23567.89 22362.11 22312 19819
Accounts Payable 460.53 562.92 474 484
Payable/Accrued - - - -
Accrued Expenses - - - -
Notes Payable/Short Term Debt 7826.17 8004.5 7910 6693
Current Port. of LT Debt/Capital Leases - - - -
Other Current liabilities, Total 15281.2 13794.68 13928 12642
Total Liabilities 42141.72 41118.73 36837 35879
Total Long Term Debt 18360.69 18683.66 14236 15960
Long Term Debt 18147.88 18440.05 13958 15643
Capital Lease Obligations - 243.61 278 317
Deferred Income Tax 84.94 - - -
Minority Interest 46.22 68.71 84 155
Other Liabilities, Total -7744.19 -8000.25 -26108.64 -25151.64
Total Equity 34160.63 30252.98 31721 26736
Redeemable Preferred Stock, Total - - - -
Preferred Stock - Non Redeemable, Net - - - -
Common Stock, Total 9679.07 9679.07 9679 9679
Additional Paid-In Capital 2358.49 2358.49 2356 2306
Retained Earnings (Accumulated Deficit) - 15479.24 15483 13890
Treasury Stock - Common -0.42 -0.42 -0.42 -0.42
ESOP Debt Guarantee - - - -
Unrealized Gain (Loss) - - - -
Other Equity, Total 4907.64 2736.61 4203 861
Total Liabilities & Shareholders' Equity 76302.35 71371.71 68558 62615
Total Common Shares Outstanding - 41.63 41.63 41.63
Total Preferred Shares Outstanding - - - -
* In Millions of JPY (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the balance sheet, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

2395 Comments

Write your thoughts about Shin Nippon Biomedical Laboratories Ltd
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email